NCT02058472View on ClinicalTrials.gov

Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Healthy Adult Volunteers
Interventions
DRUG

G3041

DRUG

SEVIKAR®

Sponsors
All Listed Sponsors
collaborator

Dong-A ST Co., Ltd.

INDUSTRY

lead

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY

NCT02058472 - Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter